All Stories

  1. Obesity and the gut microbiota in the Middle East: a cross-cultural study of Lebanese and Emirati adults
  2. A head-to-head comparison of soluble dietary fibers on microbiota composition and short-chain fatty acid production using the in vitro TIM-2 system
  3. KEGGaNOG: A Lightweight Tool for KEGG Module Profiling From Orthology‐Based Annotations
  4. Gut microbiota, SCFA and nutritional intake in stunted children in East Nusa Tenggara, Indonesia
  5. Effect of a 6-Month Functional Food Intervention on the Microbiota of Stunted Children in East Nusa Tenggara, Indonesia—A Randomized Placebo-Controlled Parallel Trial
  6. Evidence of synbiotic potential of oat beverage enriched with inulin and fermented by L. rhamnosus LR B in a dynamic in vitro model of human colon
  7. Distinct gut microbiota and metabolome features of tissue-specific insulin resistance in overweight and obesity
  8. Specific dietary fibers steer toward distal colonic saccharolytic fermentation using the microbiota of individuals with overweight/obesity
  9. Assessing the potential for non-digestible carbohydrates toward mitigating adverse effects of antibiotics on microbiota composition and activity in an in vitro colon model of the weaning infant
  10. Changes in energy homeostasis, gut peptides, and gut microbiota in Emiratis with obesity after bariatric surgery
  11. Gut microbiota composition of lean and obese Lebanese individuals
  12. Bacillus megaterium DSM 32963 Enhances Specialized Pro-Resolving Mediator Production from an n-3 PUFA Salt in a Dynamic Model of the Human Intestine
  13. Unlocking the potential of fermented beetroot ketchup: Enhancing polyphenol recovery and gut microbiota interactions
  14. Investigating the ROS Formation and Particle Behavior of Food-Grade Titanium Dioxide (E171) in the TIM-1 Dynamic Gastrointestinal Digestion Model
  15. Beetroot ketchup as a stable carrier of potential probiotic Lacticaseibacillus rhamnosus K3 and Lactobacillus johnsonii K4: A study on sensory attributes, storage viability, and in vitro gastrointestinal survival
  16. Gut microbiota modulatory capacity of fermented ketchup in a validated in vitro model of the colon
  17. Examination of sex-specific interactions between gut microbiota and host metabolism after 12-week combined polyphenol supplementation in individuals with overweight or obesity
  18. Modulation of Poultry Cecal Microbiota by a Phytogenic Blend and High Concentrations of Casein in a Validated In Vitro Cecal Chicken Alimentary Tract Model
  19. Assessment of protein and phospholipid bioaccessibility in ultrafiltered buttermilk cheese using TIM-1 in vitro gastrointestinal methods
  20. Modulation of human gut microbiota by linear and branched fructooligosaccharides in anin vitrocolon model (TIM-2)
  21. Gut microbiota of captive common bottlenose dolphins Tursiops truncatus gilli: influence of age, sex, birthplace, and contacts with dolphinarium visitors
  22. The effect of concentrated buttermilk on cheese milk rennet-induced coagulation and rheological properties at various buttermilk to skim milk ratios
  23. Gut microbiota differences in stunted and normal-lenght children aged 36–45 months in East Nusa Tenggara, Indonesia
  24. Gut Microbiota Composition of Insectivorous Synanthropic and Fructivorous Zoo Bats: A Direct Metagenomic Comparison
  25. Modulation of Swine Gut Microbiota by Phytogenic Blends and High Concentrations of Casein in a Validated Swine Large Intestinal In Vitro Model
  26. Cultivable Gut Microbiota in Synanthropic Bats: Shifts of Its Composition and Diversity Associated with Hibernation
  27. Identifying a Complex Carbohydrate Mixture in Context of a High-Protein Diet That Is Able to Steer Microbial Fermentation to Improve Metabolic Health: The DISTAL Study
  28. Citrus Extract High in Flavonoids Beneficially Alters Intestinal Metabolic Responses in Subjects with Features of Metabolic Syndrome
  29. Investigating the survival and activity of a bacteriophage in the complex colon environment with the use of a dynamic model of the colon (TIM-2)
  30. Fecal levels of SCFA and BCFA during capecitabine in patients with metastatic or unresectable colorectal cancer
  31. Homogenization of monthly series of temperature and precipitation: Benchmarking results of the MULTITEST project
  32. Influence of the gut microbiota on satiety signaling
  33. Effect of Protein Fermentation Products on Gut Health Assessed in an In Vitro Model of Human Colon (TIM‐2)
  34. Effect of reverse osmosis and ultra-high-pressure homogenization on the composition and microstructure of sweet buttermilk
  35. Detection of coronaviruses in insectivorous bats of Fore-Caucasus, 2021
  36. Studying Fungal-Bacterial Relationships in the Human Gut Using an In Vitro Model (TIM-2)
  37. Fungal-Bacterial Interactions in the Human Gut of Healthy Individuals
  38. Modelling the Gut Fungal-Community in TIM-2 with a Microbiota from Healthy Individuals
  39. Use of Tunable Copolymers in Aqueous Biphasic Systems for Extractive Bioconversion Aimed at Continuous Fructooligosaccharide Production
  40. Mono-Parasitic and Poly-Parasitic Intestinal Infections among Children Aged 36–45 Months in East Nusa Tenggara, Indonesia
  41. Butyrate and hexanoate-enriched triglycerides increase postprandrial systemic butyrate and hexanoate in men with overweight/obesity: A double-blind placebo-controlled randomized crossover trial
  42. Investigation of the impact of black chokeberry polyphenols in different matrices on the human gut microbiota using the in vitro model of the large intestine (TIM-2)
  43. A systematic review of breast milk microbiota composition and the evidence for transfer to and colonisation of the infant gut
  44. The Association of Peptide Hormones with Glycemia, Dyslipidemia, and Obesity in Lebanese Individuals
  45. Dietary supplementation with selenomethionine enhances antioxidant capacity and selenoprotein gene expression in layer breeder roosters
  46. Mild intermittent hypoxia exposure alters gut microbiota composition in men with overweight and obesity
  47. Chemical and nutritional characteristics, and microbial degradation of rapeseed meal recalcitrant carbohydrates: A review
  48. Gibberellic Acid and Indole Acetic Acid Improves Salt Tolerance in Transgenic Tomato Plants Overexpressing LeNHX4 Antiporter
  49. Changes in intestinal microbiota in postmenopausal oestrogen receptor-positive breast cancer patients treated with (neo)adjuvant chemotherapy
  50. Chicken-derived RSPO1 and WNT3 contribute to maintaining longevity of chicken intestinal organoid cultures
  51. Structure and function of non-digestible carbohydrates in the gut microbiome
  52. Animal-free strategies in food safety & nutrition: What are we waiting for? Part II: Nutrition research
  53. Insights from 20 years of temperature parallel measurements in Mauritius around the turn of the 20th century
  54. Unravelling salt tolerance mechanisms in plants: From lab to field
  55. The Association between Peptide Hormones with Obesity and Insulin Resistance Markers in Lean and Obese Individuals in the United Arab Emirates
  56. Foreword – Into the third year with COVID-19. Will gut microbiota be shown to play a role?
  57. Effect of Different Functional Food Supplements on the Gut Microbiota of Prediabetic Indonesian Individuals during Weight Loss
  58. Fiber mixture-specific effect on distal colonic fermentation and metabolic health in lean but not in prediabetic men
  59. Intestinal Microbiota in Postmenopausal Breast Cancer Patients and Controls
  60. A blend of 3 mushrooms dose-dependently increases butyrate production by the gut microbiota
  61. A Citrus Fruit Extract High in Polyphenols Beneficially Modulates the Gut Microbiota of Healthy Human Volunteers in a Validated In Vitro Model of the Colon
  62. Development of the in vitro Cecal Chicken ALIMEntary tRact mOdel-2 to Study Microbiota Composition and Function
  63. In vitro gastrointestinal digestion and colonic fermentation of tomato (Solanum lycopersicum L.) and husk tomato (Physalis ixocarpa Brot.): Phenolic compounds released and bioconverted by gut microbiota
  64. Lean and obese microbiota: differences in in vitro fermentation of food-by-products
  65. Differences in immune status and fecal SCFA between Indonesian stunted children and children with normal nutritional status
  66. Multi‐objective downscaling of precipitation time series by genetic programming
  67. Effect of Taro Starch, Beet Juice, Probiotic, and/or Psicose on Gut Microbiota in a Type 2 Diabetic Rat Model: A Pilot Study
  68. Bioconversion of polyphenols and organic acids by gut microbiota of predigested Hibiscus sabdariffa L. calyces and Agave (A. tequilana Weber) fructans assessed in a dynamic in vitro model (TIM-2) of the human colon
  69. Impact of a fermented soy beverage supplemented with acerola by-product on the gut microbiota from lean and obese subjects using an in vitro model of the human colon
  70. Efficiency of Time Series Homogenization: Method Comparison with 12 Monthly Temperature Test Datasets
  71. Improved yield, fruit quality, and salt resistance in tomato co-overexpressing LeNHX2 and SlSOS2 genes
  72. Health benefits of whole grain: effects on dietary carbohydrate quality, the gut microbiome, and consequences of processing
  73. Loss of function of the chloroplast membrane K+/H+ antiporters AtKEA1 and AtKEA2 alters the ROS and NO metabolism but promotes drought stress resilience
  74. Foreword – The importance of a healthy microbiota in the era of COVID-19
  75. Gut microbiota profile of Indonesian stunted children and children with normal nutritional status
  76. Bioconversion by gut microbiota of predigested mango (Mangifera indica L) ‘Ataulfo’ peel polyphenols assessed in a dynamic (TIM-2) in vitro model of the human colon
  77. Study of the impact of a dynamic in vitro model of the colon (TIM-2) in the phenolic composition of two Mexican sauces
  78. Correction to Cellulase and Alkaline Treatment Improve Intestinal Microbial Degradation of Recalcitrant Fibers of Rapeseed Meal in Pigs
  79. Animal-free strategies in food safety & nutrition: What are we waiting for? Part I: Food safety
  80. Plastidial transporters KEA1 and KEA2 at the inner envelope membrane adjust stromal pH in the dark
  81. Pretreatment of Rapeseed Meal Increases Its Recalcitrant Fiber Fermentation and Alters the Microbial Community in an in vitro Model of Swine Large Intestine
  82. Phenolic Compounds Promote Diversity of Gut Microbiota and Maintain Colonic Health
  83. Polysaccharide source altered ecological network, functional profile, and short-chain fatty acid production in a porcine gut microbiota
  84. Effect of functional food ingredients on gut microbiota in a rodent diabetes model
  85. Cellulase and Alkaline Treatment Improve Intestinal Microbial Degradation of Recalcitrant Fibers of Rapeseed Meal in Pigs
  86. Differently Pre-treated Rapeseed Meals Affect in vitro Swine Gut Microbiota Composition
  87. Modulation of Gut Microbiota Profile and Short-Chain Fatty Acids of Rats Fed with Taro Flour or Taro Starch
  88. Effect of functional food ingredients on gut microbiota in a rodent diabetes model
  89. Survival of a probiotic-containing product using capsule-within-capsule technology in anin vitromodel of the stomach and small intestine (TIM-1)
  90. Is there evidence for bacterial transfer via the placenta and any role in the colonization of the infant gut? – a systematic review
  91. Calcium and phosphorus bioaccessibility from different amino acid-based medical nutrition formulas for infants and children under in vitro digestive conditions
  92. Low glycemic load after digestion of native starch from the indigenous tuber Belitung Taro (Xanthosoma sagittifolium) in a dynamic in vitro model of the upper GI tract (TIM-1)
  93. Potential of High- and Low-Acetylated Galactoglucomannooligosaccharides as Modulators of the Microbiota Composition and Their Activity: A Comparison Using the In Vitro Model of the Human Colon TIM-2
  94. Pretreatment of Rapeseed Meal Increases Its Recalcitrant Fibre Fermentation and Alters the Microbial Community in an in Vitro Model of Swine Large Intestine
  95. Profiles of Human Milk Oligosaccharides and Their Relations to the Milk Microbiota of Breastfeeding Mothers in Dubai
  96. Changes in gut microbiota in predigested Hibiscus sabdariffa L calyces and Agave (Agave tequilana weber) fructans assessed in a dynamic in vitro model (TIM-2) of the human colon
  97. Interaction of dietary polyphenols and gut microbiota: Microbial metabolism of polyphenols, influence on the gut microbiota, and implications on host health
  98. Overexpression of LeNHX4 improved yield, fruit quality and salt tolerance in tomato plants (Solanum lycopersicum L.)
  99. The topographic control on land surface energy fluxes: A statistical approach to bias correction
  100. Effect of functional food ingredients on gut microbiota in a rodent diabetes model
  101. Effect of functional food ingredients on gut microbiota in a rodent diabetes model
  102. Xylo-oligosaccharides from sugarcane show prebiotic potential in a dynamic computer-controlled in vitro model of the adult human large intestine
  103. Stability and anti-topoisomerase activity of phenolic compounds of Capsicum annuum “Serrano” after gastrointestinal digestion and in vitro colonic fermentation
  104. Modulation of equol production via different dietary regimens in an artificial model of the human colon
  105. Foreword – 10 years of Beneficial Microbes
  106. Deletion of the N‐terminal domain of the yeast vacuolar (Na+,K+)/H+ antiporter Vnx1p improves salt tolerance in yeast and transgenic Arabidopsis
  107. Differential glucose bioaccessibility from native and modified taro-starches in the absence or presence of beet juice
  108. Gastrointestinal digestion of dietary advanced glycation endproducts using anin vitromodel of the gastrointestinal tract (TIM-1)
  109. Prebiotic effects of pectooligosaccharides obtained from lemon peel on the microbiota from elderly donors using an in vitro continuous colon model (TIM-2)
  110. Effect of potato fiber on survival of Lactobacillus species at simulated gastric conditions and composition of the gut microbiota in vitro
  111. Random trend errors in climate station data due to inhomogeneities
  112. Probiotic survival during a multi‐layered tablet development as tested in a dynamic, computer‐controlledin vitromodel of the stomach and small intestine (TIM‐1)
  113. A Limited Role for Unforced Internal Variability in Twentieth-Century Warming
  114. Microbial communities in a dynamic in vitro model for the human ileum resemble the human ileal microbiota
  115. Degradation of fibres from fruit by-products allows selective modulation of the gut bacteria in an in vitro model of the proximal colon
  116. A new method to study inhomogeneities in climate records: Brownian motion or random deviations?
  117. Effects of functional pastas on gut microbiota from healthy, pre-diabetic and diabetic children.
  118. Prebiotic effect of predigested mango peel on gut microbiota assessed in a dynamic in vitro model of the human colon (TIM-2)
  119. Survival, metabolic status and cellular morphology of probiotics in dairy products and dietary supplement after simulated digestion
  120. Impact of plant sterols enrichment dose on gut microbiota from lean and obese subjects using TIM-2 in vitro fermentation model
  121. Potential of Pectins to Beneficially Modulate the Gut Microbiota Depends on Their Structural Properties
  122. Spores ofBacillus coagulansGBI-30, 6086 show high germination, survival and enzyme activity in a dynamic, computer-controlledin vitromodel of the gastrointestinal tract
  123. Foreword – nearly 10 years of Beneficial Microbes
  124. Overexpression of LeNHX2 and SlSOS2 increases salt tolerance and fruit production in double transgenic tomato plants
  125. Microbiota composition of dadih - a traditional fermented buffalo milk of West Sumatra
  126. Gut microbial metabolites in obesity, NAFLD and T2DM
  127. Structure Dependent-Immunomodulation by Sugar Beet Arabinans via a SYK Tyrosine Kinase-Dependent Signaling Pathway
  128. Characterization and in vitro digestibility of by-products from Brazilian food industry: Cassava bagasse, orange bagasse and passion fruit peel
  129. Remembering Forgetting: Graphic Lives at the End of the Line
  130. On the reduction of trend errors by the ANOVA joint correction scheme used in homogenization of climate station records
  131. Deterministic and stochastic precipitation downscaling using multi-objective genetic programming
  132. Inter‐comparison of methods to homogenize daily relative humidity
  133. Microencapsulation increases survival of the probioticLactobacillus plantarumIS-10506, but notEnterococcus faeciumIS-27526 in a dynamic, computer-controlledin vitromodel of the upper gastrointestinal tract
  134. Towards a global land surface climate fiducial reference measurements network
  135. Foreword – Increase in clinical trials for probiotics and prebiotics
  136. “And then, nothing”: Alzheimer's archives and the good (enough) death
  137. A Call for New Approaches to Quantifying Biases in Observations of Sea Surface Temperature
  138. Supplementation of Diet With Galacto-oligosaccharides Increases Bifidobacteria, but Not Insulin Sensitivity, in Obese Prediabetic Individuals
  139. Bacillus coagulansGBI-30, 6086 increases plant protein digestion in a dynamic, computer-controlledin vitromodel of the small intestine (TIM-1)
  140. A Screening Tool to Measure Eye Contact Avoidance in Boys with Fragile X Syndrome
  141. Review on challenges in simulating gut microbiota in vitro with a focus on obesity
  142. Foreword – Probiotics and prebiotics – important dietary components for health
  143. The prebiotic landscape: history, health and physiological benefits, and regulatory challenges – an IPA perspective part 1
  144. Recommendations for the use of standardised abbreviations for the former Lactobacillus genera, reclassified in the year 2020
  145. Effects of Liver Resection on Hepatic Short-Chain Fatty Acid Metabolism in Humans
  146. Infant social attention: an endophenotype of ASD‐related traits?
  147. Downscaling near-surface atmospheric fields with multi-objective Genetic Programming
  148. Protein architecture and core residues in unwound α-helices provide insights to the transport function of plant AtCHX17
  149. Effects of in vitro fermentation of barley β‐glucan and sugar beet pectin using human fecal inocula on cytokine expression by dendritic cells
  150. Envelope K+/H+ Antiporters AtKEA1 and AtKEA2 Function in Plastid Development
  151. The Gut Microbiota from Lean and Obese Subjects Contribute Differently to the Fermentation of Arabinogalactan and Inulin
  152. The effect of agave fructan products on the activity and composition of the microbiota determined in a dynamic in vitro model of the human proximal large intestine
  153. The impact of lemon pectin characteristics on TLR activation and T84 intestinal epithelial cell barrier function
  154. Reduced engagement with social stimuli in 6-month-old infants with later autism spectrum disorder: a longitudinal prospective study of infants at high familial risk
  155. Proton Gradients and Proton-Dependent Transport Processes in the Chloroplast
  156. Foreword: probiotics and prebiotics – a field that is alive and kicking
  157. Diet drives quick changes in the metabolic activity and composition of human gut microbiota in a validated in vitro gut model
  158. Assessment of parallel precipitation measurements networks in Piedmont, Italy
  159. Microbial Metabolism Shifts Towards an Adverse Profile with Supplementary Iron in the TIM-2 In vitro Model of the Human Colon
  160. Evaluation of an optimal preparation of human standardized fecal inocula for in vitro fermentation studies
  161. The use of fecal samples for studying human obesity
  162. Developmental changes in infant brain activity during naturalistic social experiences
  163. Assessing digestibility of Hadza tubers using a dynamic in‐vitro model
  164. Hepatic Uptake of Rectally Administered Butyrate Prevents an Increase in Systemic Butyrate Concentrations in Humans
  165. Characterisation and in vitro fermentation of resistant maltodextrins using human faecal inoculum and analysis of bacterial enzymes present
  166. Erratum to: In vitro digestion of starches in a dynamic gastrointestinal model: an innovative study to optimize dietary management of patients with hepatic glycogen storage diseases
  167. The art of targeting gut microbiota for tackling human obesity
  168. The uncertainty of break positions detected by homogenization algorithms in climate records
  169. Determination of amylose/amylopectin ratio of starches
  170. Does the Gut Microbiota Contribute to Obesity? Going beyond the Gut Feeling
  171. Gut microbiota and obesity: Involvement of the adipose tissue
  172. Corrigendum to “Prebiotic effects of cassava bagasse in TNO's in vitro model of the colon in lean versus obese microbiota” [Journal of Functional Foods 11 (2014) 210–220]
  173. Foreword - there is still tremendous interest in probiotics and prebiotics
  174. To pool or not to pool? Impact of the use of individual and pooled fecal samples for in vitro fermentation studies
  175. In Vitro Characterization of the Impact of Different Substrates on Metabolite Production, Energy Extraction and Composition of Gut Microbiota from Lean and Obese Subjects
  176. Ion antiport accelerates photosynthetic acclimation in fluctuating light environments
  177. Prebiotic effects of cassava bagasse in TNO's in vitro model of the colon in lean versus obese microbiota
  178. Immunological Properties of Inulin-Type Fructans
  179. A framework for benchmarking of homogenisation algorithm performance on the global scale
  180. In vitro digestion of starches in a dynamic gastrointestinal model: an innovative study to optimize dietary management of patients with hepatic glycogen storage diseases
  181. Utility of models of the gastrointestinal tract for assessment of the digestion and absorption of engineered nanomaterials released from food matrices
  182. Effect of Soluble and Insoluble Fibers within the in Vitro Fermentation of Chicory Root Pulp by Human Gut Bacteria
  183. The fate of chicory root pulp polysaccharides during fermentation in the TNO in vitro model of the colon (TIM-2)
  184. Toll-Like Receptor 2 Activation by β2→1-Fructans Protects Barrier Function of T84 Human Intestinal Epithelial Cells in a Chain Length–Dependent Manner
  185. Foreword
  186. Effect of the Novel Polysaccharide PolyGlycopleX® on Short-Chain Fatty Acid Production in a Computer-Controlled in Vitro Model of the Human Large Intestine
  187. Foreword
  188. In Vitro Fermentability of Sugar Beet Pulp Derived Oligosaccharides Using Human and Pig Fecal Inocula
  189. Approaches that ascertain the role of dietary compounds in colonic cancer cells
  190. Different Human Gut Models Reveal the Distinct Fermentation Patterns of Arabinoxylan versus Inulin
  191. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism
  192. Immune Modulation by Different Types of β2→1-Fructans Is Toll-Like Receptor Dependent
  193. The K+/H+antiporter LeNHX2 increases salt tolerance by improving K+homeostasis in transgenic tomato
  194. Alterations in mucosal neuropeptides in patients with irritable bowel syndrome and ulcerative colitis in remission: A role in pain symptom generation?
  195. Foreword
  196. Experimental models of the gut microbiome
  197. Genome Instability in Lactobacillus rhamnosus GG
  198. Benchmarking homogenization algorithms for monthly data
  199. Effect of galactooligosaccharides andBifidobacterium animalisBb-12 on growth ofLactobacillus amylovorusDSM 16698, microbial community structure, and metabolite production in anin vitrocolonic model set up with human or pig microbiota
  200. The human gastrointestinal microbiota—An unexplored frontier for pharmaceutical discovery
  201. Early Behavioral Intervention Is Associated With Normalized Brain Activity in Young Children With Autism
  202. Reduction of radiation biases by incorporating the missing cloud variability by means of downscaling techniques: a study using the 3-D MoCaRT model
  203. Influence ofBacillus subtilisC-3102 on microbiota in a dynamicin vitromodel of the gastrointestinal tract simulating human conditions
  204. Arabidopsis KEA2, a homolog of bacterial KefC, encodes a K+/H+ antiporter with a chloroplast transit peptide
  205. Immunomodulatory effects of potential probiotics in a mouse peanut sensitization model
  206. Galacto-Oligosaccharides Have Prebiotic Activity in a Dynamic In Vitro Colon Model Using a 13C-Labeling Technique
  207. Effects of probiotics and antibiotics on the intestinal homeostasis in a computer controlled model of the large intestine
  208. Disaggregation of screen-level variables in a numerical weather prediction model with an explicit simulation of subgrid-scale land-surface heterogeneity
  209. Foreword
  210. Alternative procedure to shorten rectal barostat procedure for the assessment of rectal compliance and visceral perception: a feasibility study
  211. Expression of LeNHX isoforms in response to salt stress in salt sensitive and salt tolerant tomato species
  212. Intestinal fermentation of lactose and prebiotic lactose derivatives, including human milk oligosaccharides
  213. Benchmarking homogenization algorithms for monthly data
  214. Conserved and Diversified Gene Families of Monovalent Cation/H+ Antiporters from Algae to Flowering Plants
  215. Natural Three-Dimensional Predictor Domains for Statistical Precipitation Downscaling
  216. Developmental Change in the ERP Responses to Familiar Faces in Toddlers With Autism Spectrum Disorders Versus Typical Development
  217. Propionic acid affects immune status and metabolism in adipose tissue from overweight subjects
  218. Effect of bioprocessing of wheat bran in wholemeal wheat breads on the colonic SCFA production in vitro and postprandial plasma concentrations in men
  219. In vitro evaluation of gastrointestinal survival of Lactobacillus amylovorus DSM 16698 alone and combined with galactooligosaccharides, milk and/or Bifidobacterium animalis subsp. lactis Bb-12
  220. Application of an adaptive radiative transfer scheme in a mesoscale numerical weather prediction model
  221. Metabolite Production during in Vitro Colonic Fermentation of Dietary Fiber: Analysis and Comparison of Two European Diets
  222. Re: Pitino et al. (2010) Food Microbiology 27:1121–1127 “Survival of Lactobacillus rhamnosus strains in the upper gastrointestinal tract”
  223. Evidence for a sodium efflux mechanism in the leaf cells of the seagrass Zostera marina L.
  224. Foreword
  225. Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remission
  226. Foreword
  227. Measuring non-steady-state metabolic fluxes in starch-converting faecal microbiota in vitro
  228. Measuring non-steady-state metabolic fluxes in starch-converting faecal microbiotain vitro
  229. Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms
  230. Evaluating the microbial diversity of an in vitro model of the human large intestine by phylogenetic microarray analysis
  231. Butyrate enemas do not affect human colonic MUC2 and TFF3 expression
  232. Role of gut microbiota in the control of energy and carbohydrate metabolism
  233. Short chain fatty acids exchange: Is the cirrhotic, dysfunctional liver still able to clear them?
  234. Regulation of adipokine production in human adipose tissue by propionic acid
  235. Preface by the Editor-in-chief
  236. Microfiltration sampling in rats and in cows: toward a portable device for continuous glucocorticoidhormone sampling
  237. A new algorithm for the downscaling of cloud fields
  238. Starch-entrapped microspheres show a beneficial fermentation profile and decrease in potentially harmful bacteria duringin vitrofermentation in faecal microbiota obtained from patients with inflammatory bowel disease
  239. Short chain fatty acids exchange across the gut and liver in humans measured at surgery
  240. The Effect of the Undigested Fraction of Maize Products on the Activity and Composition of the Microbiota Determined in a Dynamicin VitroModel of the Human Proximal Large Intestine
  241. Heterologous Processing and Export of the Bacteriocins Pediocin PA-1 and Lactococcin A in Lactococcus Lactis: A Study with Leader Exchange
  242. Butyrate-Induced Transcriptional Changes in Human Colonic Mucosa
  243. The effects of butyrate enemas on visceral perception in healthy volunteers
  244. Analyses of human colonic mucus obtained by an in vivo sampling technique
  245. Profiling human gut bacterial metabolism and its kinetics using [U-13C]glucose and NMR
  246. Linking phylogenetic identities of bacteria to starch fermentation in an in vitro model of the large intestine by RNA‐based stable isotope probing
  247. Bioconversion of red ginseng saponins in the gastro-intestinal tract in vitro model studied by high-performance liquid chromatography–high resolution Fourier transform ion cyclotron resonance mass spectrometry
  248. Butyrate modulates oxidative stress in the colonic mucosa of healthy humans
  249. The role of colonic metabolism in lactose intolerance
  250. Review article: the role of butyrate on colonic function
  251. Application of liquid chromatography–mass spectrometry to measure the concentrations and study the synthesis of short chain fatty acids following stable isotope infusions
  252. Differential analysis of protein expression of Bifidobacterium grown on different carbohydrates
  253. Identification of glucose-fermenting bacteria present in an in vitro model of the human intestine by RNA-stable isotope probing
  254. Gaining Insight into Microbial Physiology in the Large Intestine: A Special Role for Stable Isotopes
  255. In vitro fermentability of differently digested resistant starch preparations
  256. Digestibility of resistant starch containing preparations using two in vitro models
  257. Statistical characteristics of surrogate data based on geophysical measurements
  258. Beyond diversity: functional microbiomics of the human colon
  259. Of the Major Phenolic Acids Formed during Human Microbial Fermentation of Tea, Citrus, and Soy Flavonoid Supplements, Only 3,4-Dihydroxyphenylacetic Acid Has Antiproliferative Activity ,
  260. The influence of microbial metabolites on human intestinal epithelial cells and macrophages in vitro
  261. D-Tagatose increases butyrate production by the colonic microbiota in healthy men and women
  262. In vitro sampling and storage of proteins with an ultrafiltration collection device (UCD) and analysis with absorbance spectrometry and SELDI-TOF-MS
  263. The Metabolic Activity of Fecal Microbiota from Healthy Individuals and Patients with Inflammatory Bowel Disease
  264. The Effect of Lactulose on the Composition of the Intestinal Microbiota and Short-chain Fatty Acid Production in Human Volunteers and a Computer-controlled Model of the Proximal Large Intestine
  265. The Effect of Various Inulins andClostridium difficileon the Metabolic Activity of the Human Colonic Microbiotain vitro
  266. DNA analysis of the genes encoding acidocin LF221 A and acidocin LF221 B, two bacteriocins produced by Lactobacillus gasseri LF221
  267. A PCR-based method for identification of bifidobacteria from the human alimentary tract at the species level
  268. A Novel Intracellular K+/H+ Antiporter Related to Na+/H+ Antiporters Is Important for K+ Ion Homeostasis in Plants
  269. Molecular cloning and characterisation of three new ATP-binding cassette transporter genes from the wheat pathogen Mycosphaerella graminicola
  270. Bifidobacteria:  Genetic Modification and the Study of Their Role in the Colon
  271. Control of bioflavour and safety in fermented sausages: first results of a European project
  272. Rapid and Efficient Purification Method for Small, Hydrophobic, Cationic Bacteriocins: Purification of Lactococcin B and Pediocin PA-1
  273. Multidrug resistance mediated by a bacterial homolog of the human multidrug transporter MDR1.
  274. Mutational analysis and chemical modification of Cys24 of lactococcin B, a bacteriocin produced by Lactococcus lactis
  275. The genes for secretion and maturation of lactococcins are located on the chromosome of Lactococcus lactis IL1403
  276. Topology of LcnD, a protein implicated in the transport of bacteriocins from Lactococcus lactis
  277. Expression of lactococcin A and pediocin PA-1 in heterologous hosts
  278. Functional analysis of the pediocin operon of Pediococcus acidilactici PAC1.0: PedB is the immunity protein and PedD is the precursor processing enzyme
  279. Lactococcal bacteriocins: mode of action and immunity
  280. Lactococcins: Mode of action, immunity and secretion
  281. Mode of action of LciA, the lactococcin A immunity protein
  282. Mode of Action of Lactococcin B, a Thiol-Activated Bacteriocin from Lactococcus lactis
  283. Molecular cloning and sequence analysis of the X-prolyl dipeptidyl aminopeptidase gene from Lactococcus lactis subsp. cremoris